Company
Epana Bio
Reset immunity. Restore health.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Epana Bio
Claim, correct or request removal
Record updated 28 September 2026
About
Epana Bio is building a first-in-class platform to transform the treatment of autoimmune disease. They leverage AI-driven insights around novel targets and biology to develop precision T-cell engagers (TCEs)—bispecific antibodies that simultaneously target disease drivers and activate T-cells to eliminate them. This novel approach unlocks a new therapeutic modality for a $50B+ market with urgent unmet need.
Loading relationship preview